nav emailalert searchbtn searchbox tablepage yinyongbenwen piczone journalimg journalInfo journalinfonormal searchdiv searchzone qikanlogo popupnotification paper paperNew
2024, 04, v.43 415-418+440
巢国俊应用“扶阳消阴,培本通络”法治疗视网膜色素变性经验
基金项目(Foundation): 中国中医科学院科技创新工程项目(编号:CI2021A02611);中国中医科学院“名医名家传承”项目(编号:CM2014GD1031); 北京市石景山区名医传承工作室师承项目(编号:1021122); 国家中医药管理局国家中医临床研究基地业务建设科研专项课题项目(编号:JDZX2015285)
邮箱(Email): zhj@126.com;
DOI: 10.16295/j.cnki.0257-358x.2024.04.016
摘要:

介绍巢国俊教授诊治视网膜色素变性临床验案。阳气为人之根本,视网膜色素变性患者本质为脾肾阳虚,阳虚气化不足导致阴邪内生,阴盛则寒,内生阴邪加之外寒之邪,寒性凝滞,进而影响阳气的通达及气血的运行,气血不能到达、濡养视网膜周边,故有夜盲之象。临床诊治视网膜色素变性应当以阴阳为纲,补虚扶本,兼顾气血,遵循“病在阳者,扶阳抑阴”,先温补脾肾之阳,固守先后天之本,扶阳消阴,散邪通络,阳气通达,阴实消散,气血畅通,则视物夜盲改善。

Abstract:

A proved case by Professor CHAO Guojun in treating retinitis pigmentosa was introduced.Yang qi is the root of man,and therefore the essence of retinitis pigmentosa is yang deficiency of the spleen and kidney.Yang deficiency leads to insufficient qi transformation and internal generation of yin evil.Excessive yin causes cold,and with the external cold evil,for cold evil is ongealing and stagnating,movement of yang qi and circulation of qi and blood are affected.Qi and blood can’t reach and nourish the periphery of the retina,so that night blindness occurs.In clinical treatment of retinitis pigmentosa,yin and yang should be the major principle,which includes tonifying deficiency and supporting the foundation,taking into account both qi and blood,following the principle of“supporting yang and suppressing yin when the disease is in yang”,first warming and tonifying the yang of the spleen and kidney,guarding the innate and acquired foundation,supporting yang and eliminating yin,dispersing evil and unblocking collaterals.Therefore,yang qi moves smoothly,and yin excess is resolved,qi and blood circulate fluently,manifesting as the improvement of eye sight and night blindness.

参考文献

[1]段俊国.中西医结合眼科学[M].北京:中国中医药出版社,2005:286-287.

[2]HUANG Z Y,LIANG L N,LI Y M,et al. Genetic,environmental and other risk factors for progression of retinitis pigmentosa[J]. Int J Ophthalmol,2022,15(5):828-837.

[3]邓方圆,韩梦雨,邓婷婷,等.视网膜色素变性基因治疗的相关研究进展[J].国际眼科杂志,2021,21(7):1205-1208.

[4]蒋鹏飞,彭俊,欧晨,等.视网膜色素变性的实验研究进展[J].国际眼科杂志,2020,20(6):970-973.

[5]李文生,陈晓冬.遗传性视网膜疾病基因治疗临床试验现状与挑战[J].眼科,2020,29(4):241-245.

[6]陈鼓应.老子今注今译[M].北京:商务印书馆,2003:233-239.

[7]张志聪.黄帝内经素问集注[M].王洪利,吕凌,校注.北京:中国医药科技出版社,2014.

[8]汪古珊.医学萃精(上)[M].北京:国际文化出版公司,2002:45-52.

[9]郑寿全.医理真传[M].北京:中国中医药出版社,2008:47-74.

[10]张介宾.景岳全书译注[M].王大淳,主编.北京:中国人民大学出版社,2010.

[11]王肯堂.证治准绳[M].倪和宪,点校.北京:人民卫生出版社,2014:383.

[12]巢元方.诸病源候论[M].刘晓峰,点校.北京:人民军医出版社,2006.

[13]倪维德.原机启微[M].汪剑,和中浚,点评.北京:中国医药科技出版社,2021:11-13.

[14]黄元御.四圣心源[M].孙恰熙,校注,北京:中国中医药出版社,2009:133.

[15]沈金鳌.杂兵源流犀烛[M].田思胜,整理.北京:人民卫生出版社,2006:711.

[16]卢崇汉.扶阳讲记[M].北京:中国中医药出版社,2006:180.

[17]余天泰.论扶阳学派理论基础与核心思想[J].中医药通报,2011,10(01):23-25.

[18]李东垣.脾胃论[M].文魁,丁国华,整理.北京:人民卫生出版社,2005:7-14.

[19]黄庭镜.目经大成[M].李怀芝,郭君双,整理.北京:人民卫生出版社,2006:150.

[20]杨永升,庄曾渊,王影,等.对古文献中关于治疗夜盲方剂的研究[J].中国中医眼科杂志,2007,17(1):54-56.

基本信息:

DOI:10.16295/j.cnki.0257-358x.2024.04.016

中图分类号:R249;R276.7

引用信息:

[1]史随随,高君,潘红丽,等.巢国俊应用“扶阳消阴,培本通络”法治疗视网膜色素变性经验[J].山东中医杂志,2024,43(04):415-418+440.DOI:10.16295/j.cnki.0257-358x.2024.04.016.

基金信息:

中国中医科学院科技创新工程项目(编号:CI2021A02611);中国中医科学院“名医名家传承”项目(编号:CM2014GD1031); 北京市石景山区名医传承工作室师承项目(编号:1021122); 国家中医药管理局国家中医临床研究基地业务建设科研专项课题项目(编号:JDZX2015285)

发布时间:

2024-04-05

出版时间:

2024-04-05

检 索 高级检索